Abiopharma

🔍 Furman Carly Lisanne (Executive)

Company: Nayax Ltd. (NYAX)

Report Date: 2026-05-10

Detailed Transactions and Holdings:

• Acquired 12,000 shares of Ordinary Shares (Direct)
  Date: 2026-05-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 23,574.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Nayax Ltd. (the "Company"). 3,500 RSUs vest after 20 days (05/30/2026) and the remaining 8,500 vest in four equal annual installments on March 15th of each year, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date.